WITS(MD), a provider of medical image workflow solutions, announced the introduction of Image Mover, a mobile application that securely captures medical images from smart devices with a zero-protected health information (PHI) footprint.

Pingmd debuted its virtual care mobile app, Pingmd 3, at the 2015 Healthcare Information and Management Systems Society (HIMSS) annual conference, April 13-15 in Chicago. The platform allows virtual care coordination using messaging, voice, picture and video in asynchronous and real time communications securely.

The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.

CareDx Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high-value, non-invasive surveillance solutions for transplant recipients, announced new evidence that the proportion of cell-free DNA (cfDNA) derived from the transplanted organ and found in the bloodstream of the recipient is correlated to the rejection status of the organ. This new biomarker (cfDNA) in combination with AlloMap, the company's molecular diagnostic surveillance solution, provides greater accuracy of identification of rejection in heart transplant recipients than either test alone.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now